Article Versions Notes

Wakabayashi H, Kayano D, Inaki A, Araki R, Kuroda R, Akatani N, Yamase T, Watanabe S, Hiromasa T, Kunita Y, et al. Diagnostic Use of Post-therapy ¹³¹I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma. Diagnostics. 2020; 10(9):663. https://doi.org/10.3390/diagnostics10090663

Wakabayashi, Hiroshi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda, Norihito Akatani, Takafumi Yamase, Satoru Watanabe, Tomo Hiromasa, Yuji Kunita, and et al. 2020. "Diagnostic Use of Post-therapy ¹³¹I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma" Diagnostics 10, no. 9: 663. https://doi.org/10.3390/diagnostics10090663

Wakabayashi, H., Kayano, D., Inaki, A., Araki, R., Kuroda, R., Akatani, N., Yamase, T., Watanabe, S., Hiromasa, T., Kunita, Y., Mori, H., Saito, S., Ikawa, Y., Fujiki, T., & Kinuya, S. (2020). Diagnostic Use of Post-therapy ¹³¹I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma. Diagnostics, 10(9), 663. https://doi.org/10.3390/diagnostics10090663